Table 1.
Susceptibility of 20 Staphylococci isolated from breast implant infections
| Range | MIC50 | MIC90 | %S | ||
|---|---|---|---|---|---|
| S. aureus (13) | ciprofloxacin | ≤0.12-4 | ≤0.12 | 1 | 92.3 |
| cotrimoxazole | ≤2/38 | ≤2/38 | ≤2/38 | 100 | |
| clindamycin | ≤0.25 | ≤0.25 | ≤0.25 | 100* | |
| erythromycin | ≤0.25- ≥ 8 | ≤0.25 | ≥8 | 76.9 | |
| tetracycline | ≤1 | ≤1 | ≤1 | 100 | |
| rifampicin | ≤0.5 | ≤0.5 | ≤0.5 | 100 | |
| linezolid | 1 | 1 | 1 | 100 | |
| vancomycin | ≤0.5-1 | 1 | 1 | 100 | |
| oxacillin | ≤0.25-1 | 0.5 | 1 | 100 | |
| gentamicin | ≤0.25-0.5 | 0.5 | 0.5 | 100 | |
| daptomycin | 0.12-1 | 0.25 | 1 | 100 | |
| S. epidermidis (7) | ciprofloxacin | ≤0.12 | 100 | ||
| cotrimoxazole | ≤2/38-4 | 85.7 | |||
| clindamycin | ≤0.25 | 100 | |||
| erythromycin | ≤0.25- ≥ 8 | 28.6 | |||
| tetracycline | ≤1 | 100 | |||
| rifampicin | ≤0.5 | 100 | |||
| linezolid | 1 | 100 | |||
| vancomycin | 1 | 100 | |||
| oxacillin | ≤0.25-4 | 71.4 | |||
| gentamicin | ≤0.25- > 16 | 71.4 | |||
| daptomycin | 0.25-0.5 | 100 |
*Two strains showed inducible clindamycin resistance.